Literature DB >> 28656198

miR-202 functions as a tumor suppressor in non-small cell lung cancer by targeting STAT3.

Zhonghai Zhao1, Bin Lv1, Li Zhang1, Nana Zhao1, Yan Lv2.   

Abstract

MicroRNAs (miRNAs) are a group of non-protein‑coding, short single-stranded RNAs, which are considered as promising molecular markers and therapeutic targets in several cancers. The present study explored the expression patterns and functional roles of miR‑202 in non‑small cell lung cancer (NSCLC). The expression levels of miR‑202 were determined in NSCLC tissues and cell lines using reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR). The functional impact of miR‑202 overexpression on NSCLC cell viability, migration and invasion were evaluated using Cell Counting Kit‑8 reagent and Transwell migration and invasion assays, respectively. The molecular mechanism underlying the tumor suppressive roles of miR‑202 on NSCLC was examined using bioinformatics analysis, luciferase reporter assay, RT‑qPCR and western blot analysis. In addition, signal transducer and activator of transcription (STAT) 3 was overexpressed to investigate the impact on miR‑202‑mediated tumor suppression in NSCLC. The results indicated that miR‑202 was downregulated in NSCLC tissues and cell lines, and was associated with tumor node metastasis stage and lymph node metastasis. Exogenous miR‑202 expression reduced NSCLC cell viability, migration and invasion. Furthermore, STAT3 was identified as a direct target gene of miR‑202 in NSCLC. STAT3 overexpression improved miR‑202‑impaired cell viability, migration and invasion. In conclusion, the present study revealed novel anticancer effects induced by miR‑202 upregulation in NSCLC, and indicated that STAT3 may be a molecular target of miR‑202.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28656198     DOI: 10.3892/mmr.2017.6841

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   3.423


  19 in total

1.  Shikonin-mediated up-regulation of miR-34a and miR-202 inhibits retinoblastoma proliferation.

Authors:  Yan Su; Shiyou Lu; Jincun Li; Liya Deng
Journal:  Toxicol Res (Camb)       Date:  2018-06-06       Impact factor: 3.524

2.  miR-202 acts as a potential tumor suppressor in breast cancer.

Authors:  Shanshan Gao; Chunfang Cao; Qingfu Dai; Jian Chen; Jiancheng Tu
Journal:  Oncol Lett       Date:  2018-05-16       Impact factor: 2.967

3.  MicroRNA-29a Functions as a Tumor Suppressor and Increases Cisplatin Sensitivity by Targeting NRAS in Lung Cancer.

Authors:  Xin Liu; Xianping Lv; Qiankun Yang; Huifang Jin; Wenpeng Zhou; Qingxia Fan
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

4.  LncRNA MALAT1 facilitates lung metastasis of osteosarcomas through miR-202 sponging.

Authors:  Jun Zhang; Cheng-Dong Piao; Jie Ding; Zheng-Wei Li
Journal:  Sci Rep       Date:  2020-07-29       Impact factor: 4.379

5.  MiR-202 controls female fecundity by regulating medaka oogenesis.

Authors:  Stéphanie Gay; Jérôme Bugeon; Amine Bouchareb; Laure Henry; Clara Delahaye; Fabrice Legeai; Jérôme Montfort; Aurélie Le Cam; Anne Siegel; Julien Bobe; Violette Thermes
Journal:  PLoS Genet       Date:  2018-09-10       Impact factor: 5.917

6.  miR-196a Is Able to Restore the Aggressive Phenotype of Annexin A1 Knock-Out in Pancreatic Cancer Cells by CRISPR/Cas9 Genome Editing.

Authors:  Raffaella Belvedere; Pasquale Saggese; Emanuela Pessolano; Domenico Memoli; Valentina Bizzarro; Francesca Rizzo; Luca Parente; Alessandro Weisz; Antonello Petrella
Journal:  Int J Mol Sci       Date:  2018-07-06       Impact factor: 5.923

7.  Overexpression of miR-202 resensitizes imatinib resistant chronic myeloid leukemia cells through targetting Hexokinase 2.

Authors:  Yingjun Deng; Xin Li; Jinxin Feng; Xiangliang Zhang
Journal:  Biosci Rep       Date:  2018-05-08       Impact factor: 3.840

8.  miR-202-5p inhibits the migration and invasion of osteosarcoma cells by targeting ROCK1.

Authors:  Congda Li; Deying Ma; Jinhu Yang; Xiangbo Lin; Bo Chen
Journal:  Oncol Lett       Date:  2018-05-10       Impact factor: 2.967

9.  Shikonin sensitizes A549 cells to TRAIL-induced apoptosis through the JNK, STAT3 and AKT pathways.

Authors:  Zhi Lan Guo; Jing Zhe Li; Yan Yan Ma; Dan Qian; Ju Ying Zhong; Meng Meng Jin; Peng Huang; Lu Yang Che; Bing Pan; Yi Wang; Zhen Xiao Sun; Chang Zhen Liu
Journal:  BMC Cell Biol       Date:  2018-12-29       Impact factor: 4.241

10.  miR-202 functions as a tumor suppressor in hepatocellular carcinoma by targeting HK2.

Authors:  Jiangang Wang; Jili Chen; Fang Sun; Zhiwei Wang; Wenfang Xu; Yafeng Yu; Feng Ding; Huajiang Shen
Journal:  Oncol Lett       Date:  2020-01-23       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.